4-[(8-cycloheptyl-7-oxo-pyrido[2,3-d]pyrimidin-2-yl)amino]piperidine-1-sulfonamide

ID: ALA4753883

PubChem CID: 134247563

Max Phase: Preclinical

Molecular Formula: C19H28N6O3S

Molecular Weight: 420.54

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  NS(=O)(=O)N1CCC(Nc2ncc3ccc(=O)n(C4CCCCCC4)c3n2)CC1

Standard InChI:  InChI=1S/C19H28N6O3S/c20-29(27,28)24-11-9-15(10-12-24)22-19-21-13-14-7-8-17(26)25(18(14)23-19)16-5-3-1-2-4-6-16/h7-8,13,15-16H,1-6,9-12H2,(H2,20,27,28)(H,21,22,23)

Standard InChI Key:  PFJVPPHRFDWODX-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   30.5126   -0.6108    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.9253   -1.3207    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   31.3337   -0.6083    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.4651   -1.7375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.4639   -2.5571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1720   -2.9660    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.1702   -1.3287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8788   -1.7339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8776   -2.5591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5877   -2.9705    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.3035   -2.5612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.3047   -1.7360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5901   -1.3201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.0101   -2.9718    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.7559   -2.9651    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.0485   -2.5559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0486   -1.7391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3452   -1.3300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6348   -1.7346    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.6322   -2.5527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3400   -2.9663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2194   -1.7281    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.5854   -3.7876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.3151   -4.1407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4968   -4.9394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8451   -4.1391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9901   -5.5789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6625   -4.9370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1740   -5.5756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  8 13  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 11 14  2  0
  5 15  1  0
 15 16  1  0
 16 17  1  0
 16 21  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 19  2  1  0
  2 22  1  0
 10 23  1  0
 23 24  1  0
 24 25  1  0
 23 26  1  0
 25 27  1  0
 26 28  1  0
 27 29  1  0
 28 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4753883

    ---

Associated Targets(Human)

CCND1 Tchem CDK6/cyclin D1 (322 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNE1 Tchem Cyclin-dependent kinase 2/cyclin E1 (1877 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 420.54Molecular Weight (Monoisotopic): 420.1944AlogP: 1.77#Rotatable Bonds: 4
Polar Surface Area: 123.21Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 11.44CX Basic pKa: 2.70CX LogP: 0.82CX LogD: 0.82
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.73Np Likeness Score: -1.26

References

1. Abdel-Magid AF..  (2021)  Potential of Cyclin-Dependent Kinase Inhibitors as Cancer Therapy.,  12  (2): [PMID:33603963] [10.1021/acsmedchemlett.1c00017]

Source